# Properties of mRNA: Structure, Function, and Stability

## Introduction to mRNA Properties

Messenger RNA (mRNA) is the single-stranded ribonucleic acid molecule that carries genetic information from DNA in the nucleus to ribosomes in the cytoplasm, where it directs protein synthesis. It is the transient intermediary in [the central dogma of molecular biology](/blog/news/the-central-dogma-of-molecular-biology): DNA → RNA → Protein. Unlike DNA, which is stable and confined to the nucleus, mRNA is inherently labile, allowing cells to rapidly adjust protein production in response to changing physiological conditions.

The properties of mRNA can be grouped into four broad categories: primary structure (the linear sequence of nucleotides and its terminal modifications), secondary and tertiary structure (local and global folding), chemical modifications (covalent alterations to individual nucleotides), and stability (the molecular determinants of its half-life). Each property is not merely descriptive; each directly influences how efficiently an mRNA is transcribed, processed, exported, translated, and ultimately degraded. Understanding these properties is essential for interpreting gene expression data, designing mRNA-based therapeutics, and grasping the regulatory logic of the cell.

## Primary Structure of mRNA

The primary structure of a mature eukaryotic mRNA is a linear polymer of ribonucleotides, typically 500 to 10,000 nucleotides in length, organized into distinct functional regions. From the 5' end to the 3' end, these regions are: the 5' cap, the 5' untranslated region (5' UTR), the coding sequence (CDS), the 3' untranslated region (3' UTR), and the poly(A) tail. Each region has a specific role in mRNA metabolism, and mutations or alterations in any of them can have profound consequences for gene expression.

### 5' Cap and 5' UTR

The 5' cap is a modified guanosine nucleotide linked to the first transcribed nucleotide via a unique 5'-to-5' triphosphate bridge. The structure is 7-methylguanosine (m⁷G), added co-transcriptionally when the nascent transcript is approximately 20–30 nucleotides long. The capping reaction occurs in three steps: RNA triphosphatase removes the terminal phosphate, guanylyltransferase adds GMP in a 5'-5' linkage, and guanine-N7-methyltransferase adds a methyl group to the N7 position of the guanine. In higher eukaryotes, the first and second nucleotides adjacent to the cap are often additionally methylated at the 2'-O position of the ribose, producing cap 1 and cap 2 structures.

The 5' cap serves four critical functions. First, it protects the mRNA from 5'→3' exonucleolytic degradation by enzymes such as XRN1. Second, it is required for efficient translation initiation: the cap is bound by eukaryotic initiation factor 4E (eIF4E), which recruits the 43S preinitiation complex to the mRNA. Third, it promotes splicing of the first intron and facilitates nuclear export. Fourth, it serves as a mark of "self" for the innate immune system, distinguishing host mRNA from foreign RNA lacking a cap.

The 5' UTR is the sequence between the cap and the start codon (AUG). It typically ranges from 20 to 200 nucleotides in length, though some mRNAs have much longer 5' UTRs. The 5' UTR contains regulatory elements that influence translation efficiency. The most important is the Kozak consensus sequence (gccRccAUGG, where R is a purine), which surrounds the start codon and is required for optimal ribosome recognition. The 5' UTR can also contain upstream open reading frames (uORFs), which are short coding sequences upstream of the main start codon; these uORFs can attenuate translation of the downstream main ORF by causing premature ribosome dissociation. Additionally, stable secondary structures in the 5' UTR, such as stem-loops, can impede ribosome scanning and reduce translation initiation.

### Coding Sequence

The coding sequence (CDS) begins at the start codon (AUG, encoding methionine) and ends at one of three stop codons (UAA, UAG, or UGA). It is the region that is translated into protein. The CDS is read in triplets (codons) in the 5'→3' direction, and the genetic code is degenerate: 61 codons encode 20 amino acids, meaning most amino acids are specified by more than one codon. The choice among synonymous codons is not random; it correlates with tRNA abundance and is termed codon usage bias. Highly expressed genes tend to use codons that match the most abundant tRNAs, which speeds up translation elongation and reduces the error rate. Codon optimality also affects mRNA stability: in yeast and mammals, transcripts enriched in optimal codons are more stable than those with rare codons, a phenomenon linked to the activity of the CCR4-NOT deadenylase complex.

The CDS also contains the actual sequence that determines protein folding, and it is under strong selective pressure to maintain the [amino acid sequence](/blog/guides/amino-acid-sequence). However, the CDS can also harbor regulatory elements, such as exonic splicing enhancers (ESEs) and silencers (ESSs), which are bound by serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs) to regulate splicing. The CDS is typically 300 to 3,000 nucleotides long, but can be much larger; the human dystrophin mRNA, for example, has a CDS of approximately 11,000 nucleotides.

### 3' UTR and Poly(A) Tail

The 3' UTR is the sequence between the stop codon and the poly(A) tail. It is highly variable in length, ranging from 50 to several thousand nucleotides. The 3' UTR is a major hub for post-transcriptional regulation. It contains binding sites for microRNAs (miRNAs), [RNA-binding proteins](/knowledge/molecular-biology/rna-binding-protein) (RBPs), and AU-rich elements (AREs), all of which modulate mRNA stability and translation. The 3' UTR also determines mRNA localization: for example, the β-actin mRNA contains a zipcode sequence in its 3' UTR that directs it to the leading edge of migrating fibroblasts.

The poly(A) tail is a stretch of 50–250 adenosine residues added to the 3' end of the mRNA in the nucleus. Polyadenylation is coupled to cleavage of the pre-mRNA at a site defined by the [polyadenylation signal](/knowledge/molecular-biology/polyadenylation-signal) AAUAAA, located 10–30 nucleotides upstream of the cleavage site, and a downstream GU-rich element. The cleavage and polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CstF) recognize these sequences, and poly(A) polymerase adds the adenosine residues. The poly(A) tail is bound by poly(A)-binding protein (PABP), which protects the mRNA from 3'→5' degradation and stimulates translation initiation by interacting with eIF4G (which is bound to the 5' cap via eIF4E). This circularization of the mRNA—cap-eIF4E-eIF4G-PABP-poly(A) tail—enhances translation by promoting ribosome recycling.

## Secondary and Tertiary Structure of mRNA

mRNA is not a linear, unstructured molecule. It folds into complex secondary and tertiary structures that are determined by its [nucleotide sequence](/knowledge/molecular-biology/nucleotide-sequence). These structures are dynamic and can be remodeled by RNA-binding proteins and by the ribosome during translation.

### Role of Secondary Structures

The most common secondary structure in mRNA is the stem-loop (hairpin), formed when a palindromic sequence folds back on itself, with complementary bases pairing via Watson-Crick (A-U, G-C) and wobble (G-U) interactions. Stem-loops can be as short as 4 base pairs or as long as several hundred. The stability of a stem-loop is determined by its GC content, length, and the presence of bulges or internal loops. The free energy of folding (ΔG) can be predicted by algorithms such as Mfold or RNAfold, and typical stable stem-loops have ΔG values of −10 to −30 kcal/mol.

Secondary structures in the 5' UTR generally inhibit translation by blocking ribosome scanning. For example, the human ferritin heavy chain mRNA contains an iron-responsive element (IRE) in its 5' UTR—a stem-loop that, when bound by iron regulatory proteins (IRPs), prevents ribosome binding and represses translation. In contrast, secondary structures in the 3' UTR can either stabilize or destabilize mRNA. Some 3' UTR stem-loops protect the mRNA from deadenylation by sequestering the poly(A) tail, while others create binding sites for destabilizing proteins.

### Impact on Translation Initiation

The rate-limiting step of translation is initiation, and mRNA structure plays a decisive role. The 43S preinitiation complex (comprising the 40S ribosomal subunit, eIF2-GTP-Met-tRNAᵢ, and other initiation factors) binds to the 5' cap and scans the 5' UTR in a 5'→3' direction until it encounters the start codon. Stable secondary structures with a ΔG of less than −30 kcal/mol can stall the scanning ribosome and reduce translation initiation by 10- to 100-fold. However, some mRNAs contain internal ribosome entry sites (IRESs)—highly structured elements that allow cap-independent translation initiation, often used under stress conditions when cap-dependent translation is globally repressed.

mRNA tertiary structure refers to long-range interactions between distant regions of the molecule, such as the interaction between the 5' cap and the poly(A) tail described above. These long-range interactions can bring the 5' and 3' UTRs into close proximity, facilitating the exchange of regulatory proteins and the recycling of ribosomes. Techniques such as selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) and in-cell RNA structure probing have revealed that mRNA structure is not static; it changes in response to cellular conditions, such as heat shock, which globally denatures mRNA structure and alters translation patterns.

## Chemical Modifications of mRNA

Beyond the 5' cap, mRNA contains numerous internal chemical modifications. More than 170 distinct RNA modifications have been identified across all RNA species, and mRNA carries a subset of these. The most abundant and best-studied is N6-methyladenosine (m⁶A), but others include N1-methyladenosine (m¹A), 5-methylcytosine (m⁵C), pseudouridine (Ψ), and 2'-O-methylation (Nm).

### N6-Methyladenosine (m⁶A)

N6-methyladenosine is the most prevalent internal modification in eukaryotic mRNA, present at an average of 1–2 m⁶A residues per transcript, though some transcripts carry many more. The modification is installed co-transcriptionally by the methyltransferase complex, which includes METTL3 and METTL14 as the catalytic core, along with regulatory subunits such as WTAP and VIRMA. The complex recognizes the consensus motif DRACH (D = A/G/U, R = A/G, H = A/C/U), and m⁶A is enriched near stop codons and in 3' UTRs.

m⁶A is reversible. The fat mass and obesity-associated protein (FTO) and ALKBH5 are demethylases that remove the methyl group. The functional consequences of m⁶A are mediated by reader proteins. YTHDF2, the best-characterized reader, binds m⁶A and promotes mRNA degradation by recruiting the CCR4-NOT deadenylase complex. YTHDF1 enhances translation by interacting with eIF3. YTHDC1, a nuclear reader, regulates [alternative splicing](/blog/guides/alternative-splicing) and nuclear export. Thus, m⁶A acts as a dynamic mark that can either promote or repress gene expression depending on the reader protein and the cellular context.

The biological importance of m⁶A is underscored by its role in development and disease. Knockout of METTL3 in mouse embryonic stem cells leads to defective differentiation, and dysregulation of m⁶A has been implicated in multiple cancers, including acute myeloid leukemia and glioblastoma.

### Other Modifications

Pseudouridine (Ψ) is a modification in which the uracil base is isomerized to a C-glycoside. It is incorporated into mRNA at low levels but is of particular interest because its presence in in vitro-transcribed mRNA used in vaccines increases translation and reduces innate immune activation. N1-methyladenosine (m¹A) is found at low levels and can disrupt Watson-Crick base pairing, potentially affecting translation. 5-methylcytosine (m⁵C) is installed by NSUN2 and has been implicated in mRNA export and stability, though its functions are less well understood than those of m⁶A.

The presence of these modifications has practical implications. For example, in vitro-transcribed mRNA for therapeutic use is routinely synthesized with N1-methylpseudouridine (m1Ψ) instead of uridine, which enhances translation efficiency and reduces activation of pattern recognition receptors such as TLR3, TLR7, and RIG-I. This is a key property exploited in the design of mRNA vaccines.

## mRNA Stability and Degradation

The half-life of mRNA varies widely, from minutes to days, and is a major determinant of protein output. In human cells, the median mRNA half-life is approximately 10 hours, but individual transcripts range from less than 30 minutes (e.g., c-fos, c-myc) to more than 24 hours (e.g., β-globin). The stability of an mRNA is determined by its sequence elements, its modifications, and the activity of the degradation machinery.

### Poly(A) Tail and Deadenylation

The primary pathway of mRNA degradation begins with deadenylation—the shortening of the poly(A) tail. This is catalyzed by two main deadenylase complexes: the CCR4-NOT complex and the PAN2-PAN3 complex. CCR4-NOT is the major deadenylase in most cells and is recruited to mRNAs by various factors, including PABP-interacting proteins, ARE-binding proteins, and the m⁶A reader YTHDF2. Deadenylation proceeds in two phases: PAN2-PAN3 initially shortens the tail to approximately 110 nucleotides, and CCR4-NOT then completes the process, reducing the tail to fewer than 20 nucleotides.

Once the poly(A) tail is sufficiently shortened, the mRNA can be degraded by two routes. In the 5'→3' pathway, the Lsm1-7 complex and the decapping enzyme DCP2 remove the 5' cap, exposing the mRNA to XRN1, a 5'→3' exonuclease. In the 3'→5' pathway, the exosome complex degrades the mRNA from the 3' end. The 5'→3' pathway is generally predominant in yeast and mammalian cells.

### AU-Rich Elements

AU-rich elements (AREs) are sequences rich in adenosine and uridine, typically containing the pentamer AUUUA, found in the 3' UTRs of many labile mRNAs, particularly those encoding cytokines, growth factors, and proto-oncogenes. AREs are bound by ARE-binding proteins (ARE-BPs) that either destabilize or stabilize the mRNA. The best-studied destabilizing ARE-BP is tristetraprolin (TTP), which recruits the CCR4-NOT complex to promote deadenylation and decay. In contrast, HuR (ELAVL1) is a stabilizing ARE-BP that protects mRNA from degradation by competing with TTP and by recruiting factors that maintain the poly(A) tail. The balance between TTP and HuR determines the half-life of ARE-containing mRNAs, and this balance is regulated by phosphorylation: p38 MAPK phosphorylates TTP, inactivating it and thereby stabilizing ARE-mRNAs during stress responses.

### miRNA-Mediated Decay

MicroRNAs (miRNAs) are ~22-nucleotide non-coding RNAs that guide the RNA-induced silencing complex (RISC) to complementary sequences, typically in the 3' UTR of target mRNAs. The interaction is mediated by the seed region (nucleotides 2–8) of the miRNA, which pairs with the target mRNA. In animals, the complementarity is usually imperfect, and the primary effect is translational repression followed by mRNA destabilization. The RISC component Argonaute (AGO) recruits GW182 (TNRC6 in humans), which in turn recruits the CCR4-NOT deadenylase complex and the decapping machinery. This leads to deadenylation, decapping, and degradation of the target mRNA. It is estimated that more than 60% of human protein-coding genes are conserved targets of miRNAs, making miRNA-mediated decay a major determinant of mRNA stability.

The half-life of an mRNA is therefore not a fixed property but a dynamic parameter that reflects the integrated activity of stabilizing and destabilizing factors. For a detailed discussion of the regulatory networks controlling mRNA decay, see [mRNA Stability](/knowledge/molecular-biology/mrna-stability).

## Methods to Study mRNA Properties

Several experimental approaches are used to characterize mRNA structure, stability, and translation. Each method provides complementary information, and modern studies often combine multiple approaches.

### RNA Sequencing

RNA sequencing (RNA-seq) provides a genome-wide snapshot of mRNA abundance. In a typical experiment, total RNA is isolated, ribosomal RNA is depleted or poly(A)-selected, and the remaining RNA is converted to cDNA, fragmented, and sequenced on a high-throughput platform (e.g., Illumina). The resulting reads are aligned to a reference genome or transcriptome, and the number of reads mapping to each gene is used as a proxy for mRNA abundance. RNA-seq can also reveal [alternative splicing](/blog/guides/alternative-splicing) patterns, allele-specific expression, and the presence of novel transcripts. For studying mRNA stability, RNA-seq can be combined with transcriptional inhibitors such as actinomycin D (used at 5–10 µg/mL) or with metabolic labeling using 4-thiouridine (4sU), which allows pulse-chase experiments to measure decay rates genome-wide.

### [Ribosome Profiling](/knowledge/molecular-biology/ribosome-profiling)

Ribosome profiling (Ribo-seq) measures the positions of ribosomes on mRNA at nucleotide resolution. The method involves treating cells with cycloheximide to freeze ribosomes on mRNA, digesting the unprotected mRNA with RNase I, and isolating the ribosome-protected fragments (~28–30 nucleotides). These fragments are then sequenced and mapped to the transcriptome. The density of ribosome-protected fragments along an mRNA is a direct measure of translation efficiency. Ribo-seq can identify translation start sites, uORFs, and stalled ribosomes, and it can be used to compare translation efficiency between conditions. Combined with RNA-seq, Ribo-seq allows the calculation of translation efficiency (TE) as the ratio of ribosome footprint density to mRNA abundance.

### Reporter Assays

Reporter assays are used to study the function of specific mRNA elements. A typical reporter construct consists of a promoter, a reporter gene (e.g., firefly luciferase, Renilla luciferase, or green fluorescent protein), and a test sequence inserted into the 5' UTR, CDS, or 3' UTR. The reporter is transfected into cells, and its expression is measured by luminescence or fluorescence. For example, to test the effect of a 3' UTR on mRNA stability, the 3' UTR of interest is cloned downstream of the firefly luciferase gene, and the ratio of firefly to Renilla luciferase activity is measured. To distinguish effects on translation from effects on stability, one can measure mRNA levels by qPCR or Northern blot in parallel with protein activity. Reporter assays are also used to map miRNA binding sites: a miRNA mimic is co-transfected with a reporter carrying the putative target site, and a decrease in reporter activity indicates a functional interaction.

Other methods include RNA immunoprecipitation (RIP) and crosslinking and immunoprecipitation (CLIP) to identify RNA-protein interactions, and SHAPE-seq or DMS-seq to probe RNA secondary structure in vivo. For a broader perspective on how mRNA sequence features influence translation, see [Translatability of mRNA Sequences](/knowledge/molecular-biology/translatability-of-mrna-sequences) and [Translatability of mRNA in Vitro](/knowledge/molecular-biology/translatability-of-mrna-in-vitro).

## Common Misconceptions and Pitfalls

Students frequently encounter several conceptual difficulties when studying mRNA properties. Addressing these explicitly helps build a correct mental model.

**Confusing mRNA with DNA.** mRNA is single-stranded, contains ribose instead of deoxyribose, uses uracil instead of thymine, and is transiently synthesized from a DNA template. Unlike DNA, which is replicated and maintained, mRNA is continuously synthesized and degraded. The genetic information in mRNA is read in codons, not by base-pairing with a complementary strand.

**Overlooking the 5' cap.** The 5' cap is not just a "decoration"; it is essential for mRNA stability, translation, and immune evasion. An mRNA without a cap is rapidly degraded by 5'→3' exonucleases and is not efficiently translated. In in vitro transcription for therapeutic mRNA, the cap must be added either co-transcriptionally (using cap analogs) or enzymatically after transcription.

**Assuming all mRNA is rapidly degraded.** While some mRNAs have short half-lives, many are quite stable. The half-life of β-globin mRNA in reticulocytes is over 24 hours, and some mRNAs in oocytes persist for days or weeks. Stability is regulated and is an important determinant of protein levels.

**Thinking that mRNA structure is irrelevant.** Because mRNA is single-stranded, students sometimes assume it has no structure. In reality, mRNA folds extensively, and this folding has major functional consequences. The secondary structure of the 5' UTR is a primary determinant of translation efficiency, and misfolding can lead to disease.

**Confusing mRNA processing with splicing.** mRNA processing includes capping, splicing, and polyadenylation. Splicing is only one of these steps. The 5' cap and poly(A) tail are added to all mRNAs, while splicing only removes introns from pre-mRNA. For more detail, see [mRNA Processing](/knowledge/molecular-biology/mrna-processing) and [mRNA Splicing](/knowledge/molecular-biology/mrna-splicing).

**Assuming that mRNA modifications are rare or unimportant.** Internal modifications like m⁶A are abundant and functionally significant. The presence of m⁶A can change the fate of an mRNA, promoting its degradation or enhancing its translation, depending on the reader protein. These modifications are not static; they are dynamically regulated by writers, erasers, and readers.

**Believing that the poly(A) tail is only for stability.** While the poly(A) tail does protect mRNA from degradation, it also plays a direct role in translation initiation through its interaction with PABP and eIF4G. The poly(A) tail also influences nuclear export and mRNA localization.

**Overlooking the importance of the 3' UTR.** The 3' UTR is often dismissed as "non-coding junk," but it is a dense regulatory region containing binding sites for miRNAs, ARE-BPs, and localization elements. The length and composition of the 3' UTR are under strong evolutionary selection.

**Assuming that more mRNA means more protein.** mRNA abundance is only one determinant of protein levels. Translation efficiency, mRNA localization, and protein stability all contribute. Ribosome profiling has shown that translation efficiency varies widely among mRNAs and is independently regulated.

**Forgetting that mRNA is a therapeutic agent.** The properties of mRNA are not just academic; they are exploited in mRNA vaccines and therapeutics. The stability, translatability, and immunogenicity of in vitro-transcribed mRNA are engineered by modifying the cap, the UTRs, the codon usage, and the nucleotide modifications. For a discussion of how mRNA vaccines differ from traditional vaccines, see [Difference Between mRNA and Non mRNA Vaccine](/knowledge/molecular-biology/difference-between-mrna-and-non-mrna-vaccine).

## Frequently Asked Questions

### What are the main properties of mRNA?

The main properties of mRNA are: (1) it is single-stranded and composed of ribonucleotides (A, U, G, C); (2) it carries a 5' cap and a 3' poly(A) tail; (3) it is organized into distinct regions (5' UTR, CDS, 3' UTR); (4) it folds into secondary and tertiary structures; (5) it contains internal chemical modifications such as m⁶A; and (6) it has a finite half-life that is regulated by sequence elements and RNA-binding proteins.

### How does mRNA structure affect its function?

mRNA structure affects every step of gene expression. The 5' cap and poly(A) tail promote translation and stability. Secondary structures in the 5' UTR can block ribosome scanning and reduce translation. Structures in the 3' UTR can create binding sites for regulatory proteins and miRNAs. Long-range interactions between the 5' and 3' ends circularize the mRNA and enhance translation. Overall, mRNA structure is a dynamic regulatory layer that integrates signals from the environment.

### What is the half-life of mRNA?

The half-life of mRNA ranges from minutes to days. In human cells, the median half-life is approximately 10 hours. Short-lived mRNAs (e.g., c-fos, c-myc) have half-lives of 30 minutes or less, while stable mRNAs (e.g., β-globin) have half-lives exceeding 24 hours. Half-life is determined by the poly(A) tail length, the presence of AREs, miRNA binding sites, and codon optimality.

### What is the role of the 5' cap in mRNA?

The 5' cap (7-methylguanosine) has four main roles: (1) it protects the mRNA from 5'→3' exonucleolytic degradation; (2) it is required for efficient translation initiation via binding to eIF4E; (3) it promotes splicing and nuclear export; and (4) it distinguishes host mRNA from foreign RNA, preventing innate immune activation.

### How is mRNA stability regulated?

mRNA stability is regulated by multiple mechanisms: deadenylation of the poly(A) tail by CCR4-NOT and PAN2-PAN3; decapping by DCP2; degradation by XRN1 (5'→3') or the exosome (3'→5'); binding of stabilizing proteins such as HuR; binding of destabilizing proteins such as TTP; miRNA-mediated recruitment of the RISC complex; and the presence of m⁶A modifications that recruit YTHDF2.

### What is the difference between mRNA and DNA?

mRNA is single-stranded, contains ribose, and uses uracil instead of thymine. DNA is double-stranded, contains deoxyribose, and uses thymine. mRNA is synthesized from DNA by transcription and is degraded after serving its purpose; DNA is replicated and maintained. mRNA carries the genetic information from the nucleus to the ribosome; DNA stores the genetic blueprint.

### What are the common modifications of mRNA?

The most common internal modification is N6-methyladenosine (m⁶A), which is installed by METTL3/METTL14 and removed by FTO and ALKBH5. Other modifications include N1-methyladenosine (m¹A), 5-methylcytosine (m⁵C), pseudouridine (Ψ), and 2'-O-methylation (Nm). The 5' cap is also a modification (7-methylguanosine). These modifications affect mRNA stability, splicing, export, and translation.

## Key Takeaways

- mRNA is a single-stranded, transient intermediary that carries genetic information from DNA to ribosomes, and its properties are precisely regulated to control protein production.
- The primary structure of mRNA comprises the 5' cap, 5' UTR, coding sequence, 3' UTR, and poly(A) tail, each with distinct roles in stability, translation, and localization.
- mRNA folds into secondary structures (stem-loops) that can either inhibit translation (in the 5' UTR) or regulate stability (in the 3' UTR).
- Internal chemical modifications, especially N6-methyladenosine (m⁶A), are dynamic marks that control mRNA fate by recruiting reader proteins that promote degradation or enhance translation.
- mRNA half-life is determined by the poly(A) tail, AU-rich elements, miRNA binding, codon optimality, and the activity of deadenylases, decapping enzymes, and exonucleases.
- The 5' cap is essential for mRNA stability, translation, and immune evasion; without it, mRNA is rapidly degraded and poorly translated.
- Experimental methods such as RNA-seq, ribosome profiling, and reporter assays are essential tools for dissecting mRNA properties, and understanding these properties is critical for designing mRNA-based therapeutics.

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)